News Release 2016

• November 18, 2016

  Release of DESALEX Tablets 5mg for treatment of allergic diseases

• October 17, 2016

  Release of Alcohol free hand-sanitizer Noahtect

• October 4, 2016

  LAUNCH OF URITOS TABLETS FOR OVERACTIVE BLADDER IN THAILAND

• September 28, 2016

  MSD K.K. receives manufacturing and marketing approval for DESALEX Tablets 5mg for treatment of allergic diseases

• September 15, 2016

  MSD and Kyorin Sign Agreement on Co-Promotion of Therapeutic Agent for Allergic Rhinitis, NASONEX Nasal

• September 1, 2016

  Release of Montelukast tablets 10mg「KM」, Montelukast tablets 5mg「KM」

• July 11, 2016

  Kyorin Pharmaceutical and Kaken Pharmaceutical signed a Contract for the co-promotion of the anti-allergic therapeutic agent "desloratadine"

• June 1, 2016

  Release of Eklira 400μg Genuair 60 inhalations, a treatment for COPD

• May 25, 2016

  MSD's investigational antiallergic agent desloratadine to be exclusively marketed by Kyorin

• March 30, 2016

  Kyorin and Kissei signed an Agreement for Co-Development and Co-Marketing of KRP-114V

• February 23, 2016

  Announcement Regarding Montelukast tablets 10mg「KM」, Montelukast tablets 5mg「KM」

• February 3, 2016

  Termination of License Concerning COPD Therapeutic Drug KRP-AB1102F

• 1